@article{b3526b4791894b9e94c57df0beffbed5,
title = "Induction Immunosuppressive Therapy for Kidney Transplant in Elderly Recipients: A Single-Center Experience",
author = "El-Hag, \{Amanda D\} and Ann Dao and Allam, \{Sridhar R\} and Guiteau, \{Jacfranz J\} and Madhrira, \{Machaiah M\} and Reyad, \{Ashraf I\}",
note = "Kidney transplant in patients ≥65 years is safe and feasible. Changes in this unique population's immune system warrant age-tailored regimens. We found that patients at low immunologic risk would benefit from basiliximab orthymoglobulin at 3 mg/kg. Regardless of calculated panel reactive antibodies, ...",
year = "2021",
month = apr,
day = "1",
doi = "10.6002/ECT.2020.0434",
language = "American English",
volume = "19",
journal = "Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation",
issn = "2146-8427",
number = "4",
}